TrialPsychopharmacology2012
P50 amplitude reduction: a nicotinic receptor-mediated deficit in first-degree relatives of schizophrenia patients.
Bruce I Turetsky et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it